WhiteOak Capital Pharma and Healthcare Fund - Growth - Regular Plan

Other Plans and Options
  • 0.1 %Nav, as on 12-09-2025

  • Previous Nav

  • Net Change on 12-09-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
BSE Health Care - TRI N/A N/A N/A N/A N/A N/A
BSE SENSEX - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 -1.63 22.87 19.06 1.80 8,357.03
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option Jul 13, 2018 3.41 28.37 21.82 1.88 6,161.81
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH Jul 14, 1999 3.61 26.15 20.80 1.93 3,963.38
Mirae Asset Healthcare Fund -Regular Growth Jul 02, 2018 -0.01 21.86 19.12 1.93 2,795.84
Tata India Pharma & Healthcare Fund-Regular Plan-Growth Dec 28, 2015 -1.47 23.49 19.42 2.10 1,308.56

Fund Holdings as on 31-August-2025

  • Clearing Corporation of India Ltd

  • Max Healthcare Institute Limited

  • JB Chemicals & Pharmaceuticals Limited

  • Fortis Healthcare Limited

  • Sun Pharmaceutical Industries Limited

  • Cipla Limited

  • Laurus Labs Limited

  • Krishna Institute Of Medical Sciences Limited

  • Apollo Hospitals Enterprise Limited

  • Vijaya Diagnostic Centre Limited

  • Neuland Laboratories Limited

  • Anthem Biosciences Limited

  • Abbott India Limited

  • Divi's Laboratories Limited

  • Thyrocare Technologies Limited

  • Sai Life Sciences Limited

  • Shaily Engineering Plastics Limited

  • Gland Pharma Limited

  • Kovai Medical Center and Hospital Limited

  • Glenmark Pharmaceuticals Limited

  • Emcure Pharmaceuticals Limited

  • Piramal Pharma Limited

  • GlaxoSmithKline Pharmaceuticals Limited

  • Ajanta Pharma Limited

  • Jupiter Life Line Hospitals Limited

  • Eris Lifesciences Limited

  • Lupin Limited

  • Pfizer Limited

  • Alembic Pharmaceuticals Limited

  • 91 Days Tbill (MD 02/10/2025)

  • AstraZeneca Pharma India Limited

  • Acutaas Chemicals Limited

  • Shilpa Medicare Limited

  • Navin Fluorine International Limited

  • Dr.Agarwals Eye Hospital Limited

  • Healthcare Global Enterprises Limited

  • Poly Medicure Limited

  • Supriya Lifescience Limited

  • PB Fintech Limited

  • Zota Health Care Limited

  • Orchid Pharma Limited

  • 182 Days Tbill (MD 04/09/2025)

  • 364 Days Tbill (MD 03/10/2025)

  • Onesource Specialty Pharma Limited

  • Jubilant Ingrevia Limited

  • Mankind Pharma Limited

  • Aster DM Healthcare Limited

  • 91 Days Tbill (MD 30/10/2025)

  • Net Receivables / (Payables)

  • Laxmi Dental Limited

  • 91 Days Tbill (MD 20/11/2025)

  • 91 Days Tbill (MD 25/09/2025)

  • 91 Days Tbill (MD 16/10/2025)

  • 182 Days Tbill (MD 23/10/2025)

  • 91 Days Tbill (MD 23/10/2025)

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Miscellaneous

  • Plastic Products

  • Chemicals

  • Medical Equipment/Supplies/Accessories

  • Fintech

View More

Fund Manager

  • Cash

  • Equity

  • Sov

View More

About WhiteOak Capital Pharma and Healthcare Fund

Scheme Analysis

WhiteOak Capital Pharma and Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to WhiteOak Capital Mutual Fund. It was launched on 06-Feb-2024 and currently has an AUM of ₹423.51 crore. WhiteOak Capital Pharma and Healthcare Fund is benchmarked against BSE Health Care - TRI as primary index and BSE SENSEX - TRI as secondary index.

The NAV of WhiteOak Capital Pharma and Healthcare Fund ended up ₹0.01(0.1%)yesterday to ₹14.088.

Among its top 3 holdings the fund has exposure to Clearing Corporation of India Ltd, and

The WhiteOak Capital Pharma and Healthcare Fund is managed by Piyush Baranwal and Ramesh Mantri.

Fund House Contact

Unit No. B4, 6th Floor, Cnergy, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025

022-6918 7607
022 69187643